{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:26:50Z","timestamp":1782311210280,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["IS-BRC-1215-20007"],"award-info":[{"award-number":["IS-BRC-1215-20007"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["IS-BRC-1215-20007"],"award-info":[{"award-number":["IS-BRC-1215-20007"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["IS-BRC-1215-20007"],"award-info":[{"award-number":["IS-BRC-1215-20007"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the all Manchester NIHR Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41431-021-01029-y","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T02:02:26Z","timestamp":1642989746000},"page":"458-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants"],"prefix":"10.1038","volume":"30","author":[{"given":"Daniel","family":"Moualed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Heal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhtam","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hammerbeck-Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-9416","authenticated-orcid":false,"given":"Omar","family":"Pathmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Laitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-0817","authenticated-orcid":false,"given":"Miriam","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5784","authenticated-orcid":false,"given":"Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-7248","authenticated-orcid":false,"given":"Andrew","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-2206","authenticated-orcid":false,"given":"Simon","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/B978-0-444-52902-2.00054-0","volume":"115","author":"SK Lloyd","year":"2013","unstructured":"Lloyd SK, Evans DG. Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol. 2013;115:957\u201367.","journal-title":"Handb Clin Neurol"},{"key":"1029_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp-2018-318538","volume":"89","author":"DG Evans","year":"2018","unstructured":"Evans DG, Bowers NL, Tobi S, Hartley C, Wallace A, King A, et al. Schwannomatosis: a genetic and epidemiological study. J Neurol Neurosurg Psychiatry. 2018;89:1215\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1029_CR3","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41436-018-0384-y","volume":"21","author":"DG Evans","year":"2019","unstructured":"Evans DG, King AT, Tobi S, Wallace AJ, Perry M, Anup R, et al. Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing. Genet Med. 2019;21:1525\u201333.","journal-title":"Genet Med"},{"key":"1029_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1101\/gad.13.8.978","volume":"13","author":"M Giovannini","year":"1999","unstructured":"Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, Van der Valk M, Woodruff JM, Goutebroze L, et al. Schwann cell hyperplasia and tumours in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev. 1999;13:978\u201386.","journal-title":"Genes Dev"},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MOO.0b013e3282b97310","volume":"15","author":"DB Welling","year":"2007","unstructured":"Welling DB, Packer MD, Chang LS. Molecular studies of vestibular schwannomas: a review. Curr Opin Otolaryngol Head Neck Surg. 2007;15:341\u20136.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1029_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00006123-199605000-00004","volume":"38","author":"V Mautner","year":"1996","unstructured":"Mautner V, Lindenau M, Baser M, Hazim W, Tatagiba M, Hasse W, et al. The Neuroimaging and Clinical Spectrum of Neurofibromatosis 2. Neurosurgery. 1996;38:880\u20136.","journal-title":"Neurosurgery"},{"key":"1029_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3171\/2012.3.JNS111649","volume":"117","author":"MS Dirks","year":"2012","unstructured":"Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP, et al. Long-term natural history of neurofibromatosis Type 2\u2014associated intracranial tumors. J Neurosurg. 2012;117:109\u201317.","journal-title":"J Neurosurg"},{"key":"1029_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DG Evans","year":"2009","unstructured":"Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16.","journal-title":"Orphanet J Rare Dis"},{"key":"1029_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/MAO.0b013e31815a8411","volume":"28","author":"L Fisher","year":"2007","unstructured":"Fisher L, Doherty J, Lev M, Slattery W. Distribution of Nonvestibular Cranial Nerve Schwannomas in Neurofibromatosis 2. Otol Neurotol. 2007;28:1083\u201390.","journal-title":"Otol Neurotol"},{"key":"1029_CR10","doi-asserted-by":"publisher","unstructured":"Bakir M, Connor S, Thomas N, Barazi S. Trigeminal Schwannomas in Neurofibromatosis 2. J Neurol Surg B Skull Base. 2012;73 - A280 https:\/\/doi.org\/10.1055\/s-0032-1314195.","DOI":"10.1055\/s-0032-1314195"},{"key":"1029_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/MAO.0b013e3182595454","volume":"33","author":"D Moffat","year":"2012","unstructured":"Moffat D, Kasbekar A, Axon P, Lloyd S. Growth Characteristics of Vestibular Schwannomas. Otol Neurotol. 2012;33:1053\u20138.","journal-title":"Otol Neurotol"},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00129492-200606000-00018","volume":"27","author":"S Stangerup","year":"2006","unstructured":"Stangerup S, Caye-Thomasen P, Tos M, Thomsen J. The Natural History of Vestibular Schwannoma. Otol Neurotol. 2006;27:547\u201352.","journal-title":"Otol Neurotol"},{"key":"1029_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","volume":"96","author":"VF Mautner","year":"2002","unstructured":"Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study. J Neurosurg. 2002;96:223\u20138.","journal-title":"J Neurosurg"},{"key":"1029_CR14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1227\/01.neu.0000333303.79931.83","volume":"62","author":"GJ Harris","year":"2008","unstructured":"Harris GJ, Plotkin SR, MacCollin M, Bhat S, Urban T, Lev MH, et al. Three-Dimensional Volumetrics for Tracking Vestibular Schwannoma Growth in Neurofibromatosis Type 2. Neurosurgery. 2008;62:1314\u20139.","journal-title":"Neurosurgery"},{"key":"1029_CR15","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/lary.25976","volume":"126","author":"A Picry","year":"2016","unstructured":"Picry A, Bonne NX, Ding J, Aboukais R, Lejeune JP, Baroncini M, et al. Long-term Growth Rate of Vestibular Schwannoma in Neurofibromatosis 2: A Volumetric Consideration. Laryngoscope. 2016;126:2358\u201362.","journal-title":"Laryngoscope"},{"key":"1029_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00129492-200409000-00027","volume":"25","author":"WH Slattery","year":"2004","unstructured":"Slattery WH, Fisher LM, Iqbal Z, Oppenheimer M. Vestibular Schwannoma Growth Rates in Neurofibromatosis Type 2 Natural History Consortium Subjects. Otol Neurotol. 2004;25:811\u20137.","journal-title":"Otol Neurotol"},{"key":"1029_CR17","first-page":"331","volume":"59","author":"MH Ruttledge","year":"1996","unstructured":"Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han F, Chretien N, et al. Type of Mutation in the Neurofibromatosis Type 2 Gene (NF2) Frequently Determines Severity of Disease. Am J Hum Genet. 1996;59:331\u201342.","journal-title":"Am J Hum Genet"},{"key":"1029_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","volume":"77","author":"SK Selvanathan","year":"2010","unstructured":"Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, et al. Further genotype-phenotype correlations in neurofibromatosis 2. Clin Genet. 2010;77:163\u201370.","journal-title":"Clin Genet"},{"key":"1029_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, Mackeith S, Painter S, Tomkins H, et al. Genetic Severity Score predicts clinical phenotype in NF2. J Med Genet. 2017;54:657\u201364.","journal-title":"J Med Genet"},{"key":"1029_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3171\/2019.6.PEDS1947","volume":"24","author":"I Gugel","year":"2019","unstructured":"Gugel I, Grimm F, Teuber C, Kluwe L, Mautner VF, Tatagiba M, et al. Management of NF2-associated vestibular schwannomas in children and young adults: influence of surgery and clinical factors on tumor volume and growth rate. J Neurosurg Pediatr 2019;24:584\u201392.","journal-title":"J Neurosurg Pediatr"},{"key":"1029_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2273.2004.00770.x","volume":"29","author":"BF O\u2019Reilly","year":"2004","unstructured":"O\u2019Reilly BF, Mehanna H, Kishore A, Crowther JA. Growth rate of non-vestibular intracranial schwannomas. Clin Otolaryngol. 2004;29:94\u201397.","journal-title":"Clin Otolaryngol"},{"key":"1029_CR22","first-page":"495","volume":"20","author":"M Fucci","year":"1999","unstructured":"Fucci M, Buchman C, Brackman D, Berliner K. Acoustic Tumour Growth: Implications for Treatment Choices. Am J Otol. 1999;20:495\u20139.","journal-title":"Am J Otol"},{"key":"1029_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/01.mao.0000169782.69341.6d","volume":"26","author":"A Marshall","year":"2005","unstructured":"Marshall A, Owen V, Nikolopoulos T, O\u2019Donoghue G. Acoustic Schwannomas: Awareness Of Radiologic Error Will Reduce Unnecessary Treatment. Otol Neurotol. 2005;26:512\u20135.","journal-title":"Otol Neurotol"},{"key":"1029_CR24","unstructured":"DS S. 2x3 Contingency Table Exact Test Calculator. [Online];Date accessed May 2020. http:\/\/www.analyticscalculators.com."},{"key":"1029_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/biomet\/38.1-2.141","volume":"1","author":"G Freeman","year":"1951","unstructured":"Freeman G, Halton J. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951;1:141\u20139.","journal-title":"Biometrika"},{"key":"1029_CR26","unstructured":"Neurofibromatosis Type 2 Service (All Ages). In: Highly Specialised Services 2018. NHS England. pp 52\u20133."},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuchi.2015.10.006","volume":"64","author":"SK Lloyd","year":"2018","unstructured":"Lloyd SK, Evans DG. Neurofibromatosis type 2 service delivery in England. Neurochirurgie. 2018;64:375\u201380.","journal-title":"Neurochirurgie"},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","volume":"96","author":"ME Baser","year":"2002","unstructured":"Baser ME, Makariou EV, Parry DM. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2. J Neurosurg. 2002;96:217\u201322.","journal-title":"J Neurosurg"},{"key":"1029_CR29","first-page":"1","volume":"134","author":"D Lewis","year":"2020","unstructured":"Lewis D, Donofrio CA, O\u2019Leary C, Li KL, Zhu X, Williams R, et al. The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. J Neurosurg. 2020; 134:1\u201311.","journal-title":"J Neurosurg"},{"key":"1029_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0194-5998(95)70101-X","volume":"113","author":"Equilibrium CoHa.","year":"1995","unstructured":"Equilibrium CoHa. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma [vestibular schwannoma]. Otolaryngol Head Neck Surg. 1995;113:179\u201380.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00405-018-4865-z","volume":"275","author":"S Mackeith","year":"2018","unstructured":"Mackeith S, Das T, Graves M, Patterson A, Donnelly N, Mannion R, et al. A comparison of semi-automated volumetric vs linear measurement of small vestibular schwannomas. Eur Arch Otorhinolaryngol. 2018;275:867\u201374.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1029_CR32","doi-asserted-by":"publisher","first-page":"20160110","DOI":"10.1259\/bjr.20160110","volume":"89","author":"KA Morris","year":"2016","unstructured":"Morris KA, Parry A, Pretorius PM. Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment. Br J Radio. 2016;89:20160110.","journal-title":"Br J Radio"},{"key":"1029_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/jmg.2005.031302","volume":"42","author":"ME Baser","year":"2005","unstructured":"Baser ME, Mautner VF, Parry DM, Evans DG. Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet. 2005;42:903\u20136.","journal-title":"J Med Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-01029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-01029-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-01029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T23:10:44Z","timestamp":1649373044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-01029-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1038\/s41431-021-01029-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DGE, SKL and MJS are supported by the all Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007). The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}